4//SEC Filing
Car Bruce 4
Accession 0001439222-22-000019
CIK 0001439222other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 4:11 PM ET
Size
8.6 KB
Accession
0001439222-22-000019
Insider Transaction Report
Form 4
Car Bruce
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common stock
2022-02-18+6,874→ 18,793 total - Tax Payment
Common stock
2022-02-22$29.08/sh−2,041$59,352→ 16,752 total - Exercise/Conversion
Performance share units
2022-02-18−6,874→ 6,874 total→ Common stock (6,874 underlying)
Footnotes (2)
- [F1]Each performance share unit represents a contingent right to receive one share of the issuer's common stock.
- [F2]The PSUs vest as to one-third of the underlying shares of common stock, upon the achievement of each of three specified research, regulatory and commercial milestones, subject to continued service. The performance criteria for the specified regulatory milestone was determined to have been met on February 18, 2022, resulting in the vesting of the PSUs as to one-third of the underlying shares of common stock on that date. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
Documents
Issuer
AGIOS PHARMACEUTICALS, INC.
CIK 0001439222
Entity typeother
Related Parties
1- filerCIK 0001798876
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 4:11 PM ET
- Size
- 8.6 KB